申请人:Memorial Sloan-Kettering Cancer Center
公开号:US20220162209A1
公开(公告)日:2022-05-26
Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts or tautomers thereof. Also provided are pharmaceutical compositions, kits, and methods involving the inventive compounds for the treatment and/or prevention of an infectious disease (e.g., bacterial infection (e.g.,
Mycobacterium
infection (e.g., tuberculosis)). (I)